Optimising adherence to antiretroviral therapy (ART) is fundamental to sustaining virological suppression, preventing drug resistance and reducing onward transmission. Strategies to support adherence ...

Despite patients reporting preference for long-acting injectable antiretroviral therapy, few patients with HIV report using it.

The human immunodeficiency virus (HIV), the virus that causes healthy adults to become immunosuppressed, integrates its viral genetic code into the genome of the immune CD4+ T cells. While ...

Since the advent of combination antiretroviral therapy (ART) in the mid-1990s, the prognosis of people living with HIV has improved dramatically, with substantial reductions in both AIDS-related and ...

A long-acting antiretroviral treatment (LA-ART) given every four to eight weeks, and delivered with comprehensive support services, suppressed HIV in people who were previously not virologically ...

Antiretroviral therapy (ART) prescription rates among Medicare enrollees living with HIV increased from 2007 to 2019. Although age-based disparities had reduced, women and both younger and older ...

What you need to know: “The picture looks bright, and very soon, I believe Ugandans will also be able to access some of these combination treatment in the injectable form....this is still work in ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...

Please provide your email address to receive an email when new articles are posted on . The International Antiviral Society–USA Panel recently published new recommendations for managing HIV, including ...